These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31319558)

  • 21. Field Cancerization in Sporadic Colon Cancer.
    Park SK; Song CS; Yang HJ; Jung YS; Choi KY; Koo DH; Kim KE; Jeong KU; Kim HO; Kim H; Chun HK; Park DI
    Gut Liver; 2016 Sep; 10(5):773-80. PubMed ID: 27114416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
    Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
    BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Tumor
    Boughanem H; Martin-Nuñez GM; Torres E; Arranz-Salas I; Alcaide J; Morcillo S; Tinahones FJ; Crujeiras AB; Macias-Gonzalez M
    J Pers Med; 2020 Nov; 10(4):. PubMed ID: 33187096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of a prototype reverse hybridization assay and MethyLight for detection of SFRP2 promotor methylation in fecal DNA.
    Kriegshäuser G; Enko D; Zitt M; Oberwalder M; Oberkanins C; Öfner D; Zeillinger R; Maximilian Müller H
    Int J Biol Markers; 2017 Oct; 32(4):e467-e470. PubMed ID: 28777432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Body Mass Index and Mortality in Patients With Colorectal Cancer Using Causal Diagrams.
    Kroenke CH; Neugebauer R; Meyerhardt J; Prado CM; Weltzien E; Kwan ML; Xiao J; Caan BJ
    JAMA Oncol; 2016 Sep; 2(9):1137-45. PubMed ID: 27196302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylation-mediated loss of SFRP2 enhances melanoma cell invasion via Wnt signaling.
    Luo X; Wei B; Chen A; Zhao H; Huang K; Chen J
    Am J Transl Res; 2016; 8(3):1502-9. PubMed ID: 27186276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
    Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
    Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced Wnt signaling by methylation-mediated loss of SFRP2 promotes osteosarcoma cell invasion.
    Xiao Q; Yang Y; Zhang X; An Q
    Tumour Biol; 2016 May; 37(5):6315-21. PubMed ID: 26628297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediagnosis body mass index and waist-hip circumference ratio in association with colorectal cancer survival.
    Wang N; Khankari NK; Cai H; Li HL; Yang G; Gao YT; Xiang YB; Shu XO; Zheng W
    Int J Cancer; 2017 Jan; 140(2):292-301. PubMed ID: 27706816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Expression/Methylation Profile of Adipogenic and Inflammatory Transcription Factors in Adipose Tissue Are Linked to Obesity-Related Colorectal Cancer.
    Boughanem H; Cabrera-Mulero A; Hernández-Alonso P; Bandera-Merchán B; Tinahones A; Tinahones FJ; Morcillo S; Macias-Gonzalez M
    Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31652933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of iodine-125 seeds on the methylation of SFRP
    Li X; Lu P; Li B; Zhang W; Luo K
    Exp Ther Med; 2013 Nov; 6(5):1225-1228. PubMed ID: 24223648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting.
    Heiss JA; Brenner H
    Clin Epigenetics; 2017; 9():24. PubMed ID: 28270869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WNT5A Promoter Methylation Is Associated with Better Responses and Longer Progression-Free Survival in Colorectal Cancer Patients Treated with 5-Fluorouracil-Based Chemotherapy.
    Jiang G; Lin J; Wang W; Sun M; Chen K; Wang F
    Genet Test Mol Biomarkers; 2017 Feb; 21(2):74-79. PubMed ID: 28051879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic inactivation of tumor suppressor SFRP2 and point mutation in KRAS proto-oncogene in fistula-associated mucinous type anal adenocarcinoma: report of two cases.
    Sen M; Ozdemir O; Turan M; Arici S; Yildiz F; Koksal B; Goze F
    Intern Med; 2010; 49(15):1637-40. PubMed ID: 20686305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening of exon methylation biomarkers for colorectal cancer via LC-MS/MS strategy.
    Huang Q; Yang Q; Mo M; Ye X; Zhang J; Zhang L; Chen B; Li J; Cai C
    J Mass Spectrom; 2017 Dec; 52(12):860-866. PubMed ID: 28940471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylated
    Zhao G; Liu X; Liu Y; Ma Y; Yang J; Li H; Xiong S; Fei S; Zheng M; Zhao X
    J Cancer; 2021; 12(9):2665-2672. PubMed ID: 33854626
    [No Abstract]   [Full Text] [Related]  

  • 38. Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival.
    Majchrzak-Celińska A; Słocińska M; Barciszewska AM; Nowak S; Baer-Dubowska W
    J Appl Genet; 2016 May; 57(2):189-97. PubMed ID: 26337424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LINE-1 hypomethylation is neither present in rectal aberrant crypt foci nor associated with field defect in sporadic colorectal neoplasia.
    Quintanilla I; Lopez-Cerón M; Jimeno M; Cuatrecasas M; Muñoz J; Moreira L; Carballal S; Leoz ML; Camps J; Castells A; Pellisé M; Balaguer F
    Clin Epigenetics; 2014; 6(1):24. PubMed ID: 25859284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of prediagnostic body mass index with survival after colorectal cancer: Stage-specific associations.
    Kocarnik JM; Chan AT; Slattery ML; Potter JD; Meyerhardt J; Phipps A; Nan H; Harrison T; Rohan TE; Qi L; Hou L; Caan B; Kroenke CH; Strickler H; Hayes RB; Schoen RE; Chong DQ; White E; Berndt SI; Peters U; Newcomb PA
    Int J Cancer; 2016 Sep; 139(5):1065-72. PubMed ID: 27121247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.